As shown in Figure S1, STC2 is overexpressed across a range of cancers, including bladder, colon, esophagus, liver, lung, ovary, pancreas, prostate, rectum, renal cell carcinoma, skin, testis, thyroid, and uterus. Here, STC2 is linked to hereditary clear cell renal cell carcinoma.